Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Coral Laboratories Ltd
Coral Laboratories Ltd

Coral Laboratories Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 703
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹463.40
₹-6.35 (-1.35%)
461.20Low
Today’s Performance
474.80High
442.55Low
52 Week’s Performance
859.00High

bt_logoStock Performance

  • 1 Day-1.35%
  • 1 Week-5.47%
  • 1 Month-6.85%
  • 3 Months-11.04%
  • 6 Months-23.70%
  • 1 Year-43.94%
  • 3 Years13.14%
  • 5 Years7.79%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.85
  • 52-Week Low (₹)442.55
  • 52-Week High (₹)859.00
  • Price-to-Book (X)*0.78
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*9.53
  • Earnings Per Share (₹)48.62
  • Market Cap (₹ Cr.)*165.43
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Will Pharma & Hospitals Lead Markets in 2026? | Portfolio Strategy Revealed2:37Will Pharma & Hospitals Lead Markets In 2026? | Portfolio Strategy Revealed
Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
View more

bt_logoFAQ's

What was Coral Laboratories Ltd share price previously?
Coral Laboratories Ltd share price was down by -1.35% from the previous closing price of ₹469.75.
Who are peers of Coral Laboratories Ltd?
The peers of Coral Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Coral Laboratories Ltd?
The promotor/promotors of Coral Laboratories Ltd are Girish Dhameja, Sushma Chinchane, Saurabh Shah, Malay Doshi, Rajendrasinh Rana, Pooja Hindia, DHWANI KARNA DESAI.
What has been 52-week high of Coral Laboratories Ltd stocks?
The highest price of Coral Laboratories Ltd stock is ₹859.00 in the last 52-week.
What is the share price of Coral Laboratories Ltd (CORALAB) today on BSE?
As on Dec 05, 2025 Coral Laboratories Ltd (CORALAB)’s share price on BSE is Rs 463.4
What is the market cap of Coral Laboratories Ltd (CORALAB)?
The current market capitalisation of Coral Laboratories Ltd (CORALAB) is 165.43 crores
What is Coral Laboratories Ltd Share symbol?
The symbol of Coral Laboratories Ltd is .
What is the PE ratio of Coral Laboratories Ltd (CORALAB)?
The current PE ratio of Coral Laboratories Ltd (CORALAB) is 9.53.
What is the PB ratio of Coral Laboratories Ltd (CORALAB)?
The current PB ratio of Coral Laboratories Ltd (CORALAB) is 0.78.
Today’s High & Low share prices of Coral Laboratories Ltd (CORALAB) on BSE?
Today, the share price of Coral Laboratories Ltd (CORALAB) on BSE touched a high of Rs 474.8 and a low of Rs 461.2
What price did Coral Laboratories Ltd (CORALAB) shares open on the BSE today?
On BSE, the share price of Coral Laboratories Ltd (CORALAB) opened at Rs 471
What is the 52-week high of Coral Laboratories Ltd (CORALAB)?
The 52-week high price of Coral Laboratories Ltd (CORALAB) is Rs 859.00
What is the 52-week low of Coral Laboratories Ltd (CORALAB)?
The 52-week low price of Coral Laboratories Ltd (CORALAB) is Rs 442.55

bt_logoAbout Coral Labs.

Coral Laboratories Ltd, incorporated in the year 1981, has its registered office in SF-206 Silver Oak Complex, BPC Road, Vadodara, Gujarat, 390020, 91-022-2500 5245/46. The main industry in which Coral Laboratories Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Coral Laboratories Ltd is/are M A Parekh & Associates/S C Mehra & Associates LLP. In the main management, is chairman and DHWANI KARNA DESAI is the company secretary for Coral Laboratories Ltd.

  • GD
    Girish DhamejaWhole-time Director
  • SC
    Sushma ChinchaneNon Executive Director / Chief Financial Officer
  • SS
    Saurabh ShahIndependent Non Exe. Director
  • MD
    Malay DoshiIndependent Non Exe. Director
  • RR
    Rajendrasinh RanaNon Executive Director
  • PH
    Pooja HindiaIndependent Non Exe. Director
  • DKD
    DHWANI KARNA DESAICompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.